Manhattan Scientifics, Inc. (MHTX)

USD 0.0

(16.67%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - 50 Thousand 50 Thousand 50 Thousand 97 Thousand -
Cost of Revenue 1000.00 3000.00 2000.00 - - 7000.00
Gross Profit -1000.00 47 Thousand 48 Thousand 50 Thousand 97 Thousand -7000.00
Operating Expenses 703 Thousand 729 Thousand 737 Thousand 725 Thousand 1.12 Million 1.44 Million
Selling, General and Administrative Expenses 693 Thousand 718 Thousand 727 Thousand 714 Thousand 1.11 Million 1.38 Million
Research and Development Expenses 10 Thousand 11 Thousand 10 Thousand 11 Thousand 8000.00 52 Thousand
Other Expenses - - - - - -
Cost and Expenses 703 Thousand 729 Thousand 737 Thousand 725 Thousand 1.12 Million 1.44 Million
Operating Income -703 Thousand -679 Thousand -687 Thousand -675 Thousand -1.02 Million -1.44 Million
Interest Expense - 21 Thousand 26 Thousand 25 Thousand 5000.00 -
Income Tax Expense - 2.03 Million 26 Thousand 25 Thousand 5000.00 -6.88 Million
Earnings before Tax -1.16 Million -2.73 Million -3.63 Million 4.31 Million -1.22 Million -8.33 Million
Net Income -1.16 Million -4.76 Million -3.66 Million 4.31 Million -1.22 Million -8.33 Million
Earnings Per Share Basic -0.00 -0.01 -0.01 0.01 -0.00 -0.02
Earnings Per Share Diluted -0.00 -0.01 -0.01 0.01 -0.00 -0.02
Weighted Average Shares Outstanding 559.28 Million 559.28 Million 559.28 Million 558.32 Million 549.36 Million 533.78 Million
Weighted Average Shares Outstanding (Diluted) 559.28 Million 559.28 Million 559.28 Million 593.05 Million 549.36 Million 533.78 Million
Gross Margin - 0.94 0.96 1.00 1.00 -
EBIT Margin - -13.52 -13.70 -13.46 -10.55 -
Profit Margin - -95.20 -73.30 86.28 -12.65 -
EBITDA -1.16 Million -2.7 Million -3.61 Million 4.34 Million -1.21 Million -7.71 Million
Earnings Before Tax Margin - -13.58 -13.74 -13.50 -10.57 -

Income Statement Charts